01Apr
Antitrust Agencies Pivot On HSR Early Termination And Provide COVID-19 Collaboration Guidance
Over the past week, U.S. antitrust authorities have further refined their temporary merger review procedures and provided additional guidance to expedite proposed healthcare collaborations during the COVID-19 pandemic. FTC resumes HSR Act early...
By:
Husch Blackwell LLP
Related
The European Commission’s ability to block mergers in oligopolistic markets is likely to be more re...
Read More >
The Pension Schemes Bill [HL] 2019-20 (Bill) was re-introduced before Parliament on 7 January 2020. ...
Read More >
Ken Fisher of Fisher Investments is facing almost $2 billion of withdrawals from his firm as a resul...
Read More >
On December 3, 2019, the New Jersey Appellate Division upheld the dismissal of a whistleblowing clai...
Read More >
As “whistleblower” issues pervade national headlines, lawmakers in some jurisdictions, including N...
Read More >
On June 1, 2020, the U.S. Department of Justice (“DOJ”) released updated guidance entitled “Evalu...
Read More >